Brief: Odi Pharma Qtrly Loss Per Share Amounted To SEK 0.08

Odi Pharma AB (publ)

27/08/2020 17:42

Aug 27 (Reuters) - Odi Pharma AB (publ)  ODI.TE :
    * ODI PHARMA AB: PUBLICATION OF YEAR-END REPORT
    * ODI PHARMA AB (PUBL) - QTRLY LOSS PER SHARE AMOUNTED TO SEK 0.08
    * ODI PHARMA AB (PUBL) - QTRLY GROUP'S NEGATIVE NET SALES AMOUNTED TO SEK 218,520
    * ODI PHARMA AB (PUBL) - QTRLY GROUP'S LOSS AFTER FINANCIAL ITEMS AMOUNTED TO SEK 1,229,862

Source text for Eikon:  ID:nWkrlknYV 
Further company coverage:  ODI.TE 

 ((Reuters.Briefs@thomsonreuters.com;))